Pandemics: Beyond “women and children first”
Invalid Access Key! Invalid Access Key!
Media Outlets Continue Coverage Of GSK Experimental TB Vaccine Clinical Trial Results - Kaiser Family Foundation
CIDRAP News: TB vaccine candidate shows sustained protection
“In a promising development that seems to put the world a step closer to a better vaccine against tuberculosis (TB), researchers [Tuesday] published final results from a phase 2b trial, which showed nearly 50% protection against progression to active TB. The findings confirm earlier results first reported in 2018 for the adjuvanted subunit vaccine (M72/AS01E) developed by GlaxoSmithKline (GSK) and the International AIDS Vaccine Initiative (IAVI). Researchers published their findings [Tuesday] in the New England Journal of Medicine and presented them at the 50th Union World Congress on Lung Health in Hyderabad, India…” (Schnirring, 10/29).
Additional coverage of the trial results is available from The BMJ, MedPage Today, and Science Speaks.
https://ift.tt/31YLigQ
Popular posts from this blog
180+ chief medical officers to know | 2025
Facebook Facebook Email or phone Password Forgot account? Create new account You're Temporarily Blocked You're Temporarily Blocked It looks like you were misusing this feature by going too fast. You've been temporarily blocked from using it. Back English (US) Español Français (France) 中文(简体) العربية Português (Brasil) Italiano 한국어 Deutsch हिन्दी 日本語 Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Voting Information Center Privacy Policy Consumer Health Privacy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Settings Activity log Meta © 2025 innovative care :: Article Creator How Rael Disrupted The $52 Billion Feminine Care Market With K-Beauty Innovation Yanghee Pail, Founder & CEO Rael When Yanghee Paik immigrated to the United States from Korea to attend Harvard Busin...
Primary Care - North Greece Internal Medicine & Pediatrics
prepmod vaccine :: Article Creator What Went Wrong With The 'Tiny Nonprofit' Behind The State's Beleaguered Vaccine Site When Gov. Charlie Baker released vaccine eligibility to a million more Massachusetts residents last week, state websites crumpled under a virtual stampede of people rushing to secure appointments. Users were left in online limbo for hours, and many gaped at how something so critical could be entrusted to, in their eyes, flimsy web services and fragile program designs. "Foolish system. Ill-Designed. Who are the people that designed it?" seethed Steve Rosenfeld, 70, from Worcester in a written comment to WBUR after he failed to get an appointment. The nonprofit Maryland Partnership for Prevention runs one of the crucial websites that crashed last week, a service it provides in more than two dozen states across the country. The company's software allows people to register their COVID-19 vaccines and make a...
Recommended Adult Immunization Schedule, United States, 2020* | Annals of Internal Medicine
Facebook Facebook Email or phone Password Forgot account? Create new account You're Temporarily Blocked You're Temporarily Blocked It looks like you were misusing this feature by going too fast. You've been temporarily blocked from using it. Back English (US) Español Français (France) 中文(简体) العربية Português (Brasil) Italiano 한국어 Deutsch हिन्दी 日本語 Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Voting Information Center Privacy Policy Consumer Health Privacy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Settings Activity log Meta © 2025 primary care south :: Article Creator
Comments
Post a Comment